Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

B Daniel Soland

Affiliations

  • Director at Kalvista Pharmaceuticals Inc. (KALV), 2019-09-30
  • Director at Acadia Pharmaceuticals Inc (ACAD), 2019-06-28
  • Vp, Chief Operating Officer at Viropharma Inc (VPHM), 2014-01-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KALV $11.87 7,962 Director 10,000 2019-09-27 Filing
KALV $11.90 2,038 Director 2,038 2019-09-26 Filing
ACAD $22.52 3,000 10,000 2018-03-02 Filing
ACAD $24.52 2,000 7,000 2018-03-01 Filing
ACAD $24.09 3,000 5,000 2018-03-01 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VPHM $32.99 30,000 Officer 42,881 2012-03-01 Filing